Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynecol Pathol Retrieve available abstracts of 69 articles: HTML format Text format

Single Articles

May 2019
1. PADHY RR, Savage J, Kurman RJ
   Comprehensive Surgical Staging in Stage 1 Clear Cell and Endometrioid Ovarian Carcinomas: Is it Necessary?
   Int J Gynecol Pathol. 2019;38:241-246.
   PubMed     Text format     Abstract available
   
   
   
2. DITZEL HM, Strickland KC, Meserve EE, Stover E, et al
   Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC).
   Int J Gynecol Pathol. 2019;38:230-240.
   PubMed     Text format     Abstract available
   
   
   
3. YAMAMOTO S, Sakai Y
   Ovarian Sertoli-Leydig Cell Tumor With Heterologous Hepatocytes and a Hepatocellular Carcinomatous Element.
   Int J Gynecol Pathol. 2019;38:247-252.
   PubMed     Text format     Abstract available
   
   
   March 2019
4. VISHWAJEET V, Banerjee N, Dey P
   Ovarian Lipoleiomyoma: A Rare Entity.
   Int J Gynecol Pathol. 2019;38:171-174.
   PubMed     Text format     Abstract available
   
   
   
5. STALL JN, Young RH
   Granulosa Cell Tumors of the Ovary With Prominent Thecoma-like Foci: A Report of 16 Cases Emphasizing the Ongoing Utility of the Reticulin Stain in the Modern Era.
   Int J Gynecol Pathol. 2019;38:143-150.
   PubMed     Text format     Abstract available
   
   
   
6. MILLS AM, Peres LC, Meiss A, Ring KL, et al
   Targetable Immune Regulatory Molecule Expression in High-Grade Serous Ovarian Carcinomas in African American Women: A Study of PD-L1 and IDO in 112 Cases From the African American Cancer Epidemiology Study (AACES).
   Int J Gynecol Pathol. 2019;38:157-170.
   PubMed     Text format     Abstract available
   
   
   
7. WONG RW, McCluggage WG
   Sex Cord-stromal Tumors With Steroid Cell Tumor and Fibroma Components: Report of 2 Cases, Including One of Extraovarian Origin.
   Int J Gynecol Pathol. 2019;38:151-156.
   PubMed     Text format     Abstract available
   
   
   January 2019
8. SOSLOW RA, Tornos C, Park KJ, Malpica A, et al
   Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
   Int J Gynecol Pathol. 2019;38 Suppl 1:S64-S74.
   PubMed     Text format     Abstract available
   
   
   
9. MURALI R, Davidson B, Fadare O, Carlson JA, et al
   High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
   Int J Gynecol Pathol. 2019;38 Suppl 1:S40-S63.
   PubMed     Text format     Abstract available
   
   
   
10. RABBAN JT, Gilks CB, Malpica A, Matias-Guiu X, et al
    Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
    Int J Gynecol Pathol. 2019;38 Suppl 1:S25-S39.
    PubMed     Text format     Abstract available
    
    
    
11. PARK JY, Park JY, Nam JH, Kim KR, et al
    Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium.
    Int J Gynecol Pathol. 2019;38:66-70.
    PubMed     Text format     Abstract available
    
    
    
12. GAN Q, Crumley S, Broaddus RR
    Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
    Int J Gynecol Pathol. 2019;38:44-51.
    PubMed     Text format     Abstract available
    
    
    
13. TAYLOR J, McCluggage WG
    Ovarian Sex Cord-stromal Tumors With Melanin Pigment: Report of a Previously Undescribed Phenomenon.
    Int J Gynecol Pathol. 2019;38:92-96.
    PubMed     Text format     Abstract available
    
    
    
14. SRDELIC S, Kuzmic-Prusac I, Spagnoli GC, Juretic A, et al
    MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer.
    Int J Gynecol Pathol. 2019;38:59-65.
    PubMed     Text format     Abstract available
    
    
    
15. RAJENDRAN S, Jensen D, McCluggage WG
    Ganglioneuroblastoma Arising in an Ovarian Dermoid Cyst: First Report in the Literature.
    Int J Gynecol Pathol. 2019;38:103-107.
    PubMed     Text format     Abstract available
    
    
    November 2018
16. LEE PJ, McNulty S, Duncavage EJ, Heusel JW, et al
    Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Int J Gynecol Pathol. 2018;37:581-589.
    PubMed     Text format     Abstract available
    
    
    
17. BENNETT JA, Young RH, Chuang AY, Lerwill MF, et al
    Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors.
    Int J Gynecol Pathol. 2018;37:507-515.
    PubMed     Text format     Abstract available
    
    
    
18. HAZAMA Y, Moriya T, Sugihara M, Sano R, et al
    The Analysis of Cell Cycle-related Proteins in Ovarian Clear Cell Carcinoma Versus High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2018;37:516-524.
    PubMed     Text format     Abstract available
    
    
    September 2018
19. MATRAI CE, Pirog EC, Ellenson LH
    Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
    Int J Gynecol Pathol. 2018;37:405-413.
    PubMed     Text format     Abstract available
    
    
    
20. CHAPEL DB, Joseph NM, Krausz T, Lastra RR, et al
    An Ovarian Adenocarcinoma With Combined Low-grade Serous and Mesonephric Morphologies Suggests a Mullerian Origin for Some Mesonephric Carcinomas.
    Int J Gynecol Pathol. 2018;37:448-459.
    PubMed     Text format     Abstract available
    
    
    
21. AMIT A, Sabo E, Zohar Y, Trugman E, et al
    Evaluation of Microscopic Changes in Fallopian Tubes of BRCA Mutation Carriers by Morphometric Analysis of Histologic Slides: A Preliminary Pilot Study.
    Int J Gynecol Pathol. 2018;37:460-467.
    PubMed     Text format     Abstract available
    
    
    
22. FANG H, Langstraat CL, Visscher DW, Folpe AL, et al
    Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.
    Int J Gynecol Pathol. 2018;37:468-472.
    PubMed     Text format     Abstract available
    
    
    July 2018
23. BASSIOUNY D, El-Baz MA, Gamil TM, Shams N, et al
    Endometriosis-associated Ovarian Cancer is a Subset With a More Favorable Outcome and Distinct Clinical-pathologic Characteristics.
    Int J Gynecol Pathol. 2018 Jul 27. doi: 10.1097/PGP.0000000000000533.
    PubMed     Text format     Abstract available
    
    
    
24. STEWART CJR, Crook ML
    Cerebellar Differentiation in Ovarian Teratoma: A Report of 6 Cases.
    Int J Gynecol Pathol. 2018;37:316-323.
    PubMed     Text format     Abstract available
    
    
    
25. JU B, Wang J, Yang B, Sun L, et al
    Morphologic and Immunohistochemical Study of Clear Cell Carcinoma of the Uterine Endometrium and Cervix in Comparison to Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2018;37:388-396.
    PubMed     Text format     Abstract available
    
    
    
26. SINGH N, Benson JL, Gan C, Anglesio M, et al
    Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC): Implications for Assigning Primary Site and FIGO Stage.
    Int J Gynecol Pathol. 2018;37:324-330.
    PubMed     Text format     Abstract available
    
    
    
27. HOLMES M, Robb T
    A Rare Case of Primary Apocrine Adenocarcinoma Arising Within a Mature Cystic Teratoma of the Ovary, Metastatic to a Supraclavicular Lymph Node.
    Int J Gynecol Pathol. 2018;37:344-346.
    PubMed     Text format     Abstract available
    
    
    
28. BUZA N, Wong S, Hui P
    FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
    Int J Gynecol Pathol. 2018;37:305-315.
    PubMed     Text format     Abstract available
    
    
    
29. HONG S, Cui J, Li L, Buscema J, et al
    Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.
    Int J Gynecol Pathol. 2018;37:331-337.
    PubMed     Text format     Abstract available
    
    
    
30. SIMONS M, Ebisch I, de Hullu J, van Ham M, et al
    A Patient With a Low-grade Mucinous Neoplasm Involving the Ovary and Pseudomyxoma Peritonei Originating in an Isolated Intestinal Duplication.
    Int J Gynecol Pathol. 2018;37:338-343.
    PubMed     Text format     Abstract available
    
    
    May 2018
31. ONDIC O, Sidlova H, Alaghehbandan R
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000517.
    PubMed     Text format    
    
    
    
32. COY S, Meserve E, Berkowitz R, Hirsch MS, et al
    De Novo Tumors of Teratoma: Ganglioneuroma Arising From a Mature Cystic Teratoma of the Ovary.
    Int J Gynecol Pathol. 2018;37:296-300.
    PubMed     Text format     Abstract available
    
    
    
33. WOLSKY RJ, Price MA, Zaloudek CJ, Rabban JT, et al
    Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Int J Gynecol Pathol. 2018;37:262-274.
    PubMed     Text format     Abstract available
    
    
    
34. TAS EE, Yegin Akcay GF, Yildirim F, Yavuz F, et al
    Coexisting Primary Ovarian and Omental Hydatid Disease Mimicking an Ovarian Neoplasm: A Case Report.
    Int J Gynecol Pathol. 2018;37:301-304.
    PubMed     Text format     Abstract available
    
    
    
35. RONAGHY A, Xiao GQ, Santagada E, Hasanovic A, et al
    Expression of GATA-3 in Testicular and Gynecologic Mesothelial Neoplastic and Non-neoplastic Tissues.
    Int J Gynecol Pathol. 2018;37:284-289.
    PubMed     Text format     Abstract available
    
    
    
36. AL-HUSSAINI M, Al-Othman Y, Hijazi E, McCluggage WG, et al
    A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
    Int J Gynecol Pathol. 2018;37:275-283.
    PubMed     Text format     Abstract available
    
    
    
37. VAN ROMPUY AS, Vanderstichele A, Vergote I, Moerman P, et al
    Diffusely Metastasized Adenocarcinoma Arising in a Mucinous Carcinoid of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:290-295.
    PubMed     Text format     Abstract available
    
    
    March 2018
38. NIU D, Li Z, Sun L, Cao D, et al
    Carcinoid Arising From the Teratomatous Bronchial Mucosa in a Mature Cystic Teratoma of the Ovary: A Case Report.
    Int J Gynecol Pathol. 2018;37:123-127.
    PubMed     Text format     Abstract available
    
    
    
39. RAWISH KR, Buza N, Zheng W, Fadare O, et al
    Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
    Int J Gynecol Pathol. 2018;37:174-190.
    PubMed     Text format     Abstract available
    
    
    
40. ZADEH SL, Duska LR, Mills AM
    Androgen Receptor Expression in Endometrial Carcinoma.
    Int J Gynecol Pathol. 2018;37:167-173.
    PubMed     Text format     Abstract available
    
    
    
41. SINGH K, Patel N, Patil P, Paquette C, et al
    Primary Ovarian Solid Pseudopapillary Neoplasm With CTNNB1 c.98C>G (p.S33C) Point Mutation.
    Int J Gynecol Pathol. 2018;37:110-116.
    PubMed     Text format     Abstract available
    
    
    January 2018
42. XING D, Jenson EG, Zwick CA, Rodriguez FJ, et al
    Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
    Int J Gynecol Pathol. 2018;37:52-56.
    PubMed     Text format     Abstract available
    
    
    
43. LONGWORTH A, Ganesan R, Yoong AKH, Hirschowitz L, et al
    Microscopic Heterotopic Extraovarian Sex Cord-Stromal Proliferations: Expanding the Histologic Spectrum.
    Int J Gynecol Pathol. 2018;37:35-43.
    PubMed     Text format     Abstract available
    
    
    
44. SANCI M, Gungorduk K, Gulseren V, Karadeniz T, et al
    MELF Pattern for Predicting Lymph Node Involvement and Survival in Grade I-II Endometrioid-type Endometrial Cancer.
    Int J Gynecol Pathol. 2018;37:17-21.
    PubMed     Text format     Abstract available
    
    
    
45. GOLDBERG A, Hand L, DeCotiis D, Rosenblum N, et al
    Microcystic, Elongated, and Fragmented Pattern Invasion in Ovarian Endometrioid Carcinoma: Immunohistochemical Profile and Prognostic Implications.
    Int J Gynecol Pathol. 2018;37:44-51.
    PubMed     Text format     Abstract available
    
    
    May 2017
46. MARTIN DE LA FUENTE L, Malander S, Hartman L, Jonsson JM, et al
    Claudin-4 Expression is Associated With Survival in Ovarian Cancer But Not With Chemotherapy Response.
    Int J Gynecol Pathol. 2017 May 5. doi: 10.1097/PGP.0000000000000394.
    PubMed     Text format     Abstract available
    
    
    March 2017
47. SAID I, Bohm S, Beasley J, Ellery P, et al
    The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:172-179.
    PubMed     Text format     Abstract available
    
    
    
48. NEWTON CL, Brockbank E, Singh N, Faruqi A, et al
    A Case of Stage 4B Seromucinous Ovarian Borderline Tumor With Endometriosis and Review of the Literature.
    Int J Gynecol Pathol. 2017;36:195-199.
    PubMed     Text format     Abstract available
    
    
    
49. HJORTKJAER M, Waldstrom M, Jakobsen A, Kanstrup H, et al
    The Prognostic Value of BRCA1 and PARP Expression in Epithelial Ovarian Carcinoma: Immunohistochemical Detection.
    Int J Gynecol Pathol. 2017;36:180-189.
    PubMed     Text format     Abstract available
    
    
    
50. CHOUGULE A, Dey P
    Hilus Cell Heterotopia With Intraneural Eutopia.
    Int J Gynecol Pathol. 2017;36:200-202.
    PubMed     Text format    
    
    
    
51. SANGOI AR, Kshirsagar M, Horvai AE, Roma AA, et al
    SATB2 Expression Is Sensitive but Not Specific for Osteosarcomatous Components of Gynecologic Tract Carcinosarcomas: A Clinicopathologic Study of 60 Cases.
    Int J Gynecol Pathol. 2017;36:140-145.
    PubMed     Text format     Abstract available
    
    
    
52. CHEN W, Husain A, Nelson GS, Rambau PF, et al
    Immunohistochemical Profiling of Endometrial Serous Carcinoma.
    Int J Gynecol Pathol. 2017;36:128-139.
    PubMed     Text format     Abstract available
    
    
    November 2016
53. GRAY S, Chen Y, Litton T, Jallad B, et al
    Synchronous Ileal Neuroendocrine Tumor and Ovarian Steroid Cell Tumor Present in a Female With Hyperandrogenism.
    Int J Gynecol Pathol. 2016;35:554-560.
    PubMed     Text format     Abstract available
    
    
    
54. GOEBEL EA, McCluggage WG, Walsh JC
    Mitotically Active Sclerosing Stromal Tumor of the Ovary: Report of a Case Series With Parallels to Mitotically Active Cellular Fibroma.
    Int J Gynecol Pathol. 2016;35:549-553.
    PubMed     Text format     Abstract available
    
    
    
55. LIU C, Gallagher RL, Price GR, Bolton E, et al
    Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis.
    Int J Gynecol Pathol. 2016;35:561-565.
    PubMed     Text format     Abstract available
    
    
    
56. MUTUIRI AP, Nzioka A, Busarla SV, Sayed S, et al
    Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma.
    Int J Gynecol Pathol. 2016;35:537-543.
    PubMed     Text format     Abstract available
    
    
    March 2016
57. STOLNICU S, Molnar C, Barsan I, Boros M, et al
    The Impact on Survival of an Extensive Sex Cord-like Component in Mullerian Adenosarcomas: A Study Comprising 6 Cases.
    Int J Gynecol Pathol. 2016;35:147-52.
    PubMed     Text format     Abstract available
    
    
    
58. ARAUJO IB, Pinheiro MV, Zanvettor PH, Studart EJ, et al
    High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Int J Gynecol Pathol. 2016;35:176-84.
    PubMed     Text format     Abstract available
    
    
    
59. GOYAL A, Masand RP, Roma AA
    Value of PAX-8 and SF-1 Immunohistochemistry in the Distinction Between Female Adnexal Tumor of Probable Wolffian Origin and its Mimics.
    Int J Gynecol Pathol. 2016;35:167-75.
    PubMed     Text format     Abstract available
    
    
    
60. STANHISER J, Mahdi H, Rosa G, Harper H, et al
    Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma.
    Int J Gynecol Pathol. 2016;35:185-90.
    PubMed     Text format     Abstract available
    
    
    January 2016
61. KURMAN RJ, Shih IeM
    Seromucinous Tumors of the Ovary. What's in a Name?
    Int J Gynecol Pathol. 2016;35:78-81.
    PubMed     Text format     Abstract available
    
    
    
62. WHEELER L, Westhoff GL, O'Keefe MC, Kong CS, et al
    Adenocarcinoma With Breast/Adnexal and Upper Gastrointestinal Differentiation Arising in an Ovarian Mature Cystic Teratoma: A Case Report and Review of the Literature.
    Int J Gynecol Pathol. 2016;35:72-7.
    PubMed     Text format     Abstract available
    
    
    
63. OHISHI Y, Imamura H, Aman M, Shida K, et al
    Is Invasive Micropapillary Serous Carcinoma a Low-grade Carcinoma?
    Int J Gynecol Pathol. 2016;35:56-65.
    PubMed     Text format     Abstract available
    
    
    
64. KATO N, Uchigasaki S, Fukase M, Kurose A, et al
    Expression of P450 Aromatase in Granulosa Cell Tumors and Sertoli-Stromal Cell Tumors of the Ovary: Which Cells Are Responsible for Estrogenesis?
    Int J Gynecol Pathol. 2016;35:41-7.
    PubMed     Text format     Abstract available
    
    
    
65. SUDOUR-BONNANGE H, Rocourt N, Aubry E, Lervat C, et al
    A Sex Cord-stromal Tumor, Specifically a Fibroma, Arising From the Uterine Corpus: A Case Report.
    Int J Gynecol Pathol. 2016;35:33-7.
    PubMed     Text format     Abstract available
    
    
    
66. HUSSEIN YR, Broaddus R, Weigelt B, Levine DA, et al
    The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
    Int J Gynecol Pathol. 2016;35:16-24.
    PubMed     Text format     Abstract available
    
    
    
67. HUANG W, Cheng X, Ji J, Zhang J, et al
    The Application Value of HNF-1beta Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.
    Int J Gynecol Pathol. 2016;35:66-71.
    PubMed     Text format     Abstract available
    
    
    
68. VANG R, Levine DA, Soslow RA, Zaloudek C, et al
    Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.
    Int J Gynecol Pathol. 2016;35:48-55.
    PubMed     Text format     Abstract available
    
    
    
69. OKOYE EI, Bruegl AS, Fellman B, Luthra R, et al
    Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers.
    Int J Gynecol Pathol. 2016;35:8-15.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: